REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCap-xx Regulatory News (CPX)

Share Price Information for Cap-xx (CPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0825
Bid: 0.08
Ask: 0.085
Change: 0.005 (6.45%)
Spread: 0.005 (6.25%)
Open: 0.0775
High: 0.0825
Low: 0.0775
Prev. Close: 0.0775
CPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

6 Mar 2018 07:00

RNS Number : 7661G
CAP-XX Limited
06 March 2018
 

 

Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR).

 

 

 

6 March 2018

 

 

CAP-XX Limited

("CAP-XX" or the "Company")

 

Interim Results for the half-year ended 31 December 2017

 

 

CAP-XX Limited, a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems, is pleased to announce its interim results for the half-year ended 31 December 2017.

 

Key highlights

 

· Product Sales revenue of A$1.5 million (2016: A$1.3 million) up 9%

· Royalty revenue of A$0.42 million (2016: A$0.29 million) up 43% against the corresponding prior year period. Year on year, Murata royalty was up over 145% due to increased volumes across the product range

· Improved EBITDA loss of A$1.7 million (2016: loss A$1.9 million)

· Licencing negotiations continue with numerous parties. While there have been delays in finalizing these agreements, the Board remains optimistic that the most advanced of these will be concluded in the next six months

· Sales pipeline for prismatic supercapacitors, including cylindrical cans remains at high levels. First large volume cylindrical can order was shipped late in the reporting period

· Several automotive projects advancing and licensing negotiations continuing

· Acquired additional manufacturing equipment to increase production capacity and continued to reduce costs. Commissioning to be completed before the end of the current calendar year

· A small increase in overhead expenses associated with licencing negotiations and the increase in production capacity and cost reduction programme

· Cash reserves at the end of December 2017 were A$1.5 million (2016: A$0.6 million). The cash reserves at the end of December 2017 exclude the R&D Tax rebate of A$1.6 million which was received in early February 2018

 

Anthony Kongats, CEO of CAP-XX said:

"The current financial year has been another big step up for CAP-XX. The first half saw us win our first high volume order for Thinline, which will enter mass production in the current half, and completion of products for global automotive companies. We have progressed a number of licensing negotiations to an advanced stage and secured record royalty revenues from our current licences."

Electronic copies of CAP-XX's interim results for the half-year ended 31 December 2017 will shortly be available from the Company's website: www.cap-xx.com.

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker

David Hart / Alex Brearley +44 (0) 20 3328 5656

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

 

 

Chairman's statement

The last six months performance has shown steady progress on the delivery of the Company's long-term strategy. We have announced a large volume Thinline design win, the successful rollout of the cylindrical can product range, improved the size and breadth of the current sales pipeline and deployed additional manufacturing initiatives to increase capacity and reduce costs. Revenues from product sales and royalties continue to increase with contributions from both AVX and Murata. The Board remains confident that some of the licensing opportunities currently under negotiation will come to fruition, notwithstanding the recent delays encountered.

 

Total sales revenue for the six months to 31 December 2017 was A$1.5 million (2016: A$1.3 million). Product sales were up on the previous year by 9% with volumes and pricing up 3% and 9% respectively whilst the stronger Australian dollar had a negative effect of 3% on US$ denominated product revenue. Pleasingly, royalty receipts continue to grow on a year to year basis principally due to Murata which is up 145% from the previous year. AVX has advised that year on year revenue on products utilising technology licensed from CAP-XX has increased fourfold, albeit from a low base.

 

Operating expenditure continues to be tightly controlled, with the only increases being in the product and business development areas, including licencing activities. The previously announced investments in operations, resources and plant and equipment are beginning to pay dividends with most of the key initiatives having been deployed and now delivering positive outcomes. The Company has also recently acquired, at minimal cost, certain idle manufacturing assets that were located at a former contract manufacturer's site in Malaysia. These assets are being transferred to our current contract manufacturer's site and will be in operation in the second half of the current calendar year. The deployment of these assets and the acquisition of additional capacity will be critical to meet the expected increase in demand in the short to medium term.

 

The operating result for the six-month operating period ended 31 December 2017 was an EBITDA loss of A$1.7 million (2016: EBITDA loss of A$1.9 million). Cash reserves as at the end of December 2017 were A$1.5 million which was up from A$0.6 million as at in 31 December 2016. The Federal Government R&D tax rebate which was anticipated to be received in October 2017, as in past years, was delayed due to a desk top review conducted by the Australian Taxation Office. On the successful completion of the review, the rebate totalling A$1.6 million was received in early February 2018. These funds have not been included in the cash reserves position as at December 2017. The Board remains confident that the Company's short to medium cash requirements will be satisfied by the current cash reserves in addition to the expected increase in revenue receipts (from product sales, licensing and royalty receipts) and improving margins.

 

Interest in CAP-XX's small form factor product range remains high, notably for applications relating to the internet of things (IOT). In August 2017, the Company announced its first high-volume design win in the wearable market and it is anticipated that mass production revenue will commence to be recognised in the second half of the current financial year. The Company has several large volume opportunities in the sales pipeline which are being pursued with the expectation that design wins and revenue should be forthcoming before the end of the current calendar year. Some opportunities that were initially expected to be finalised in the current financial year may slip into the first half of the 2019 financial year due to a customer delaying its mass production start date. Importantly the opportunities being pursued are not concentrated on a single target market nor customer but are across several of the Company's key target markets which reinforces the CAP-XX product's widespread appeal. These opportunities span the wearable, health, building management, automotive, security, metering and energy harvesting market segments.

 

Within the last twelve months, the Company released cylindrical cells and the end customer and distributor feedback has been positive. Several significant high-volume opportunities for these cylindrical products are being evaluated and material shipments commenced during the last three months.

 

Despite the time delays associated with finalising the previously announced licensing opportunities, the Board is optimistic that several of the licensing opportunities currently under negotiation will be finalised in the short to medium term. The finalisation and realisation of licensing opportunities remains a key priority for CAP-XX's management. The Board remains confident that the most advanced of the Company's negotiations will conclude during the current half year although the final timing of these outcomes is driven by commercial considerations. However, the Company has extensive experience in negotiation with multinational corporations and recognises that the closing stages of negotiations can be protracted.

 

The Automotive market strategy remains to partner with an automotive Tier-1 or Tier-2 manufacturer for customer interface, production and sales. CAP-XX has achieved sales of small supercapacitors to two leading German car makers, one directly and one via a distributor and the Company is in advanced negotiations with a North American Tier-1 component supplier to address the market for both large and small supercapacitor devices.

 

The Company has been improving and refining its automotive offering over the last six months, and the time delays associated with product evaluation and module testing has allowed the Company to pursue other market segments interested in the Company's large supercapacitor product offering. Extensive discussions with the Australian Defence Department and several prime military contractors have introduced opportunities which are of interest to the Company. Discussions regarding these have proven fruitful and the parties are keen to move the process forward.

 

The Board is pleased with the Company's progress over the last six months. The short-term outlook is also pleasing with key customer meetings in Europe this month to add further clarity on the outlook for the second half and beyond. The Board remains confident that the Company is on track to deliver on its long-term strategy.

 

 

Patrick Elliott

Chairman

 

 

 

 

CAP-XX Limited

Consolidated statement of profit or loss

For the half-year ended 31 December 2017

 

 

Consolidated

 

 

 

Half-year 2017

Half-year 2016

 

 

 

 

Currency: Australian Dollars

 

$

$

 

 

 

 

Revenue from sale of goods and services

 

1,544,554

1,347,226

Cost of sale of goods and services

 

(1,123,455)

(1,121,004)

Gross margin (loss) on sale of goods and services

 

421,099

226,222

 

 

 

 

Other revenue

 

24,446

1,849

Other income

 

720,000

735,399

 

 

 

 

General and administrative expenses

 

(1,077,551)

(1,179,252)

Process and engineering expenses

 

(569,997)

(446,548)

Selling and marketing expenses

 

(358,159)

(345,207)

Research and development expenses

 

(781,754)

(794,698)

Other expenses

 

(67,994)

(129,776)

(Loss) before income tax

 

(1,689,910)

(1,932,011)

 

 

 

 

Income tax benefit/(expense)

 

-

-

Net loss after income tax for the half year

 

(1,689,910)

(1,932,011)

 

 

 

 

(Loss) attributable to members of CAP-XX Limited

 

(1,689,910)

(1,932,011)

 

 

 

 

Loss per share attributable to the ordinary equity holders of the company

 

Cents

Cents

Basic loss per share

 

(0.57)

(0.72)

Diluted loss per share

 

(0.57)

(0.72)

     

 

 

 

CAP-XX Limited

Consolidated statement of comprehensive income

For the half year ended 31 December 2017

 

 

 

Consolidated

 

 

 

 

 

 

 

 

2017

2016

 

Currency: Australian Dollars

 

$

$

 

Loss for the half year

 

(1,689,910)

(1,932,011)

 

Other comprehensive income

 

 

 

 

Items that may be reclassified subsequently to profit or loss

 

 

 

 

 

 

Exchange differences on translation of foreign operations

 

2,411

(22,323)

 

Other comprehensive loss for the half year, net of tax

 

2,411

(22,323)

 

Total comprehensive loss for the half year attributable to owners of CAP-XX Limited

 

(1,687,499)

(1,954,334)

 

 

 

CAP-XX Limited

Consolidated statement of financial position

As at 31 December 2017

 

 

Consolidated

 

 

31 December 2017

30 June 2017

31 December 2016

 

 

 

 

 

Currency: Australian Dollars

 

$

$

$

 

 

 

 

 

ASSETS

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

1,514,463

3,881,792

636,528

Receivables

 

264,839

419,146

280,245

Inventories

 

1,601,915

1,321,327

1,115,347

Other

 

2,430,706

1,676,618

835,850

Total current assets

 

5,811,923

7,298,883

2,867,970

 

 

 

 

 

Non-current assets

 

 

 

 

Property, plant and equipment

 

420,745

369,779

359,837

Other

 

236,507

236,507

236,507

Total non-current assets

 

657,252

606,286

596,344

 

 

 

 

 

TOTAL ASSETS

 

6,469,175

7,905,169

3,464,314

 

 

 

 

 

LIABILITIES

 

 

 

 

Current liabilities

 

 

 

 

Payables

 

1,047,310

1,013,954

620,159

Provisions

 

708,167

682,962

668,056

Total current liabilities

 

1,755,477

1,696,916

1,288,215

 

 

 

 

 

Non-current liabilities

 

 

 

 

Provisions

 

86,240

 91,756

82,652

Total non-current liabilities

 

86,240

91,756

82,652

 

 

 

 

 

TOTAL LIABILITIES

 

1,841,717

1,788,672

1,370,867

 

 

 

 

 

NET ASSETS

 

4,627,458

6,116,497

2,093,447

 

 

 

 

 

 

 

 

 

 

EQUITY

 

 

 

 

Contributed equity

 

98,389,390

98,343,719

94,603,260

Reserves

 

4,480,173

4,324,973

4,310,144

Accumulated losses

 

(98,242,105)

(96,552,195)

(96,819,957)

TOTAL EQUITY

 

4,627,458

6,116,497

2,093,447

 

 

 

 

CAP-XX Limited

Consolidated statements of changes in equity

For the half-year ended 31 December 2017

 

Consolidated

 

 

 

 

Contributed

Equity

$

Reserve

$

Accumulated losses

$

Total

$

 

 

 

 

 

 

Balance at 1 July 2016

 

94,558,726

4,035,574

(94,887,946)

3,706,354

Loss for the period as reported in the 2016 interim financial statements

 

(1,932,011)

(1,932,011)

 

Other comprehensive loss

 

- 

(22,323)

-

 

(22,323)

Transactions with owners in their capacity as owners:

 

 

 

 

 

Contributions of equity, net of transaction costs and tax

 

44,534

 

 

44,534

Employee share options ‑ value of employee services

 

 

-

296,893

-

296,893

 

 

 

 

 

 

Balance at 31 December 2016

 

94,603,260

4,310,144

 (96,819,957)

 2,093,447

 

Profit for the period as reported in the 2017 financial statements

 

- 

-

267,762

267,762

Other comprehensive income

 

- 

28,874

-

 

28,874

Transactions with owners in their capacity as owners:

 

 

 

 

 

Contributions of equity, net of transaction costs and tax

 

3,740,459

 -

 -

3,740,459

Employee share options ‑ value of employee services

 

-

(14,045)

-

(14,045)

 

 

 

 

 

 

Balance at 30 June 2017

 

98,343,719

4,324,973

 (96,552,195)

6,116,497

 

Profit for the period as reported in the 2017 interim financial statements

 

- 

-

(1,689,910)

(1,689,910)

Other comprehensive income

 

- 

2,411

-

 

2,411

Transactions with owners in their capacity as owners:

 

 

 

 

 

Contributions of equity, net of transaction costs and tax

 

45,671

 -

 -

45,671

Employee share options ‑ value of employee services

 

-

152,789

-

152,789

 

 

 

 

 

 

Balance at 31 December 2017

 

98,389,390

4,480,173

 (98,242,105)

4,627,458

 

 

 

CAP-XX Limited

Consolidated Statement of Cash Flows

For the half-year ended 31 December 2017

 

 

Consolidated

 

 

Half-year

2017

Half-year

2016

 

 

 

 

Currency: Australian Dollars

 

$

$

 

 

 

 

Cash flows from operating activities

 

 

 

Receipts from customers (inclusive of goods and services tax)

 

1,853,316

3,371,096

Payments to suppliers and employees (inclusive of goods and services tax)

 

(4,163,655)

(3,553,937)

 

 

(2,310,339)

(182,841)

Tax credit received

 

-

1,542,925

Interest received

 

24,446

1,849

Net cash (outflow) from operating activities

 

(2,285,893)

1,361,933

 

 

 

 

Cash flows from investing activities

 

 

 

Payments for property, plant and equipment

 

(129,518)

(79,247)

Net cash (outflow) from investing activities

 

(129,518)

(79,247)

 

 

 

 

Cash flows from financing activities

 

 

 

Proceeds from issue of shares

 

45,671

44,534

Proceeds from Loans

 

-

(1,000,000)

Net cash inflow from financing activities

 

45,671

(955,466)

 

 

 

 

Net (decrease) in cash and cash equivalents

 

(2,369,740)

(327,220

Cash and cash equivalents at the beginning of the half-year

 

3,881,792

331,631

Effects of exchange rate changes on cash and cash equivalents

 

2,411

(22,323)

Cash and cash equivalents at the end of the half-year

 

 

1,514,463

636,528

 

 

 

 

 

 

 

 

This general purpose interim financial report, for the half-year reporting period ended 31 December 2017, has been prepared in accordance with Australian equivalents to International Financial Reporting Standards (AIFRSs), other authoritative pronouncements of the Australian Accounting Standards Board, Urgent Issues Group Interpretations and the Corporations Act 2001. This general purpose interim financial report, for the half-year reporting period ended 31 December 2017, is (with the exception of the figures for 30 June 2017 in the Balance Sheet) unaudited.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EAADSEALPEAF
Date   Source Headline
7th May 202410:10 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
1st May 202411:08 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20249:24 amRNSHolding(s) in Company
24th Apr 20245:04 pmRNSN05/24 - CAP-XX Limited - Restoration of trading
23rd Apr 20248:36 amRNSResult of General Meeting
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company
3rd Nov 20239:05 amRNSResult of AGM and Directorate Change
3rd Nov 20237:05 amRNSAGM Trading Update
26th Oct 20232:05 pmRNSHolding(s) in Company
13th Oct 20239:45 amRNSNotice of AGM
4th Oct 20237:00 amRNSExpansion of sales operations
29th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
14th Sep 202312:29 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSPre-close Trading Update and Notice of Results
31st Jul 20239:53 amRNSHolding(s) in Company
18th Jul 202310:27 amRNSUpdate on Patent Infringement
30th Jun 20235:00 pmRNSTotal Voting Rights
13th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:53 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.